Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011010911> ?p ?o ?g. }
- W2011010911 endingPage "1992" @default.
- W2011010911 startingPage "1969" @default.
- W2011010911 abstract "Recombinants based on the attenuated vaccinia virus strains MVA and NYVAC are considered candidate vectors against different human diseases. In this study we have generated and characterized in BALB/c and in transgenic HHD mice the immunogenicity of two attenuated poxvirus vectors expressing in a single locus (TK) the codon optimized HIV-1 genes encoding gp120 and Gag-Pol-Nef (GPN) polyprotein of clade C (referred as MVA-C and NYVAC-C). In HHD mice primed with either MVA-C or NYVAC-C, or primed with DNA-C and boosted with the poxvirus vectors, the splenic T cell responses against clade C peptides spanning gp120/GPN was broad and mainly directed against Gag-1, Env-1 and Env-2 peptide pools. In BALB/c mice immunized with the homologous or the heterologous combination of poxvirus vectors or with Semliki forest virus (SFV) vectors expressing gp120/GPN, the immune response was also broad but the most immunogenic peptides were Env-1, GPN-1 and GPN-2. Differences in the magnitude of the cellular immune responses were observed between the poxvirus vectors depending on the protocol used. The specific cellular immune response triggered by the poxvirus vectors was Th1 type. The cellular response against the vectors was higher for NYVAC than for MVA in both HHD and BALB/c mice, but differences in viral antigen recognition between the vectors was observed in sera from the poxvirus-immunized animals. These results demonstrate the immunogenic potential of MVA-C and NYVAC-C as novel vaccine candidates against clade C of HIV-1." @default.
- W2011010911 created "2016-06-24" @default.
- W2011010911 creator A5000602793 @default.
- W2011010911 creator A5007165900 @default.
- W2011010911 creator A5012024258 @default.
- W2011010911 creator A5019766365 @default.
- W2011010911 creator A5020750949 @default.
- W2011010911 creator A5020871813 @default.
- W2011010911 creator A5026117026 @default.
- W2011010911 creator A5030229109 @default.
- W2011010911 creator A5030712042 @default.
- W2011010911 creator A5038734696 @default.
- W2011010911 creator A5041267408 @default.
- W2011010911 creator A5066029443 @default.
- W2011010911 creator A5084566636 @default.
- W2011010911 creator A5086632987 @default.
- W2011010911 date "2007-03-01" @default.
- W2011010911 modified "2023-10-01" @default.
- W2011010911 title "Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C" @default.
- W2011010911 cites W1482036567 @default.
- W2011010911 cites W1488803892 @default.
- W2011010911 cites W1571842523 @default.
- W2011010911 cites W1633472206 @default.
- W2011010911 cites W1655510925 @default.
- W2011010911 cites W1660391569 @default.
- W2011010911 cites W1909386356 @default.
- W2011010911 cites W1969045843 @default.
- W2011010911 cites W1978928084 @default.
- W2011010911 cites W1983177482 @default.
- W2011010911 cites W1983429866 @default.
- W2011010911 cites W1994354143 @default.
- W2011010911 cites W1994646934 @default.
- W2011010911 cites W1997677784 @default.
- W2011010911 cites W1998987175 @default.
- W2011010911 cites W2004372840 @default.
- W2011010911 cites W2005914731 @default.
- W2011010911 cites W2014627456 @default.
- W2011010911 cites W2021110185 @default.
- W2011010911 cites W2031232276 @default.
- W2011010911 cites W2034160159 @default.
- W2011010911 cites W2045274173 @default.
- W2011010911 cites W2046201973 @default.
- W2011010911 cites W2049776590 @default.
- W2011010911 cites W2049788879 @default.
- W2011010911 cites W2051712987 @default.
- W2011010911 cites W2055243021 @default.
- W2011010911 cites W2059551093 @default.
- W2011010911 cites W2060617067 @default.
- W2011010911 cites W2072325937 @default.
- W2011010911 cites W2079016419 @default.
- W2011010911 cites W2080386250 @default.
- W2011010911 cites W2080667758 @default.
- W2011010911 cites W2081825634 @default.
- W2011010911 cites W2085091876 @default.
- W2011010911 cites W2092368847 @default.
- W2011010911 cites W2092732192 @default.
- W2011010911 cites W2111391629 @default.
- W2011010911 cites W2112783842 @default.
- W2011010911 cites W2129304079 @default.
- W2011010911 cites W2138205821 @default.
- W2011010911 cites W2139871947 @default.
- W2011010911 cites W2143515497 @default.
- W2011010911 cites W2144882745 @default.
- W2011010911 cites W2148123079 @default.
- W2011010911 cites W2150366481 @default.
- W2011010911 cites W2151200015 @default.
- W2011010911 cites W2157981287 @default.
- W2011010911 cites W2159070461 @default.
- W2011010911 cites W2163549057 @default.
- W2011010911 cites W2164160151 @default.
- W2011010911 cites W2167195856 @default.
- W2011010911 cites W2180272769 @default.
- W2011010911 cites W2210178863 @default.
- W2011010911 cites W2247920240 @default.
- W2011010911 cites W2320498484 @default.
- W2011010911 cites W4239432304 @default.
- W2011010911 doi "https://doi.org/10.1016/j.vaccine.2006.11.051" @default.
- W2011010911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17224219" @default.
- W2011010911 hasPublicationYear "2007" @default.
- W2011010911 type Work @default.
- W2011010911 sameAs 2011010911 @default.
- W2011010911 citedByCount "78" @default.
- W2011010911 countsByYear W20110109112012 @default.
- W2011010911 countsByYear W20110109112013 @default.
- W2011010911 countsByYear W20110109112014 @default.
- W2011010911 countsByYear W20110109112015 @default.
- W2011010911 countsByYear W20110109112016 @default.
- W2011010911 countsByYear W20110109112017 @default.
- W2011010911 countsByYear W20110109112018 @default.
- W2011010911 countsByYear W20110109112019 @default.
- W2011010911 countsByYear W20110109112020 @default.
- W2011010911 countsByYear W20110109112021 @default.
- W2011010911 countsByYear W20110109112023 @default.
- W2011010911 crossrefType "journal-article" @default.
- W2011010911 hasAuthorship W2011010911A5000602793 @default.
- W2011010911 hasAuthorship W2011010911A5007165900 @default.
- W2011010911 hasAuthorship W2011010911A5012024258 @default.
- W2011010911 hasAuthorship W2011010911A5019766365 @default.